Basel, November 19, 2024 – Novartis has ranked first in the 2024 Access to Medicine Index (ATMI) report published today, highlighting the company’s leadership in improving access to medicines around ...

Montreal, November 15, 2024 – Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is extremely disappointed that negotiations for PLUVICTO™ (lutetium (177Lu) vipivotide tetraxetan injection), a ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Novartis Ireland were very proud that our Customer Engagement Platform team has won the Industry Pharma Award for Best Use of Technology. We were delighted that our team's innovation and commitment to ...

The Philippine Press Institute (PPI) held a health reporting workshop to help local journalists gain a deeper understanding of low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) ...

The main objective of the CWP is to improve the quality of care for patients and support the early identification, review, and medical optimisation of patients with atherosclerotic cardiovascular ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

The main objective of the CWP is to improve the quality of care for patients and support the early identification, review, and medical optimisation of patients with atherosclerotic cardiovascular ...

Media inquiry: please contact our Communications & Engagement team at [email protected] or the Media Line at 514-633-7873 Medical questions or prescription drugs:, please contact our medical ...